Cc1ccc(S(=O)(=O)N2[C@H](c3cccc(Cl)c3)CC(=O)[C@@H]3CN(S(=O)(=O)c4ccccc4C)[C@H](c4ccc(Cl)cc4)C[C@@H]32)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?